The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Mast Biosurgery sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Mast Biosurgery is a medical equipment company that designs and manufactures bioresorbable polymer implants. The company offers bioresorbable adhesion barrier film and innovative emerging technologies for a wide range of surgical applications in the biosurgery market. Its major brands are SurgiWrap, OrthoWrap, and CardioWrap. Mast Biosurgery is headquartered in Zurich city, Zurich, Switzerland. Key subsidiaries of Mast Biosurgery include MAST Biosurgery.
The key metrics of Mast Biosurgery related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Mast Biosurgery is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Mast Biosurgery.
For a detailed understanding of the performance of Mast Biosurgery, buy the report here.